BRIAN MCGEE: Open Payments
NPI 1801231329 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 59 payments from 10 companies in 2025. Trend: 2023 $334 · 2024 $919 · 2025 $1,139
Food & beverage: $1,101Education: $39
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 18 | $263 |
| Alkermes, Inc. | 14 | $230 |
| Janssen Pharmaceuticals, Inc | 9 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $178 |
| Supernus Pharmaceuticals, Inc. | 2 | $105 |
| Lundbeck LLC | 2 | $58 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: ARISTADA, AUSTEDO XR, SPRAVATO, REXULTI, UZEDY, Qelbree, ABILIFY ASIMTUFII, INVEGA.
Industry payments across LA — which companies pay providers there.
